July 23, 2017 3:23 AM ET

Pharmaceuticals

Company Overview of T-19 Inc

Company Overview

T-19 Inc manufactures and markets pharmaceutical products. The company's flagship product TUBERCIN is an immunostimulant that strengthens the human body's own immune system and assists the body in seeking out and combating cancer cells. The company is based in Honolulu, Hawaii. T-19 Inc is a former subsidiary of Hard to Treat Diseases Inc. Prior to Reverse Merger with Shenzhen Mellow Hope Pharm Industrial Co.

Honolulu, HI 

United States

Key Executives for T-19 Inc

T-19 Inc does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact T-19 Inc, please visit www.t-19.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.